{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:19:01Z","timestamp":1788967141392,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41390-020-0917-3","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T08:02:31Z","timestamp":1588320151000},"page":"756-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Randomised controlled trial: Can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas?"],"prefix":"10.1038","volume":"88","author":[{"given":"James W. C. H.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Yin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve P. G.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C. K.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill H. B.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wa-Keung","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"917_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3892\/etm.2013.1176","volume":"6","author":"L Yu","year":"2013","unstructured":"Yu, L. et al. Treatment of superficial infantile hemangiomas with timolol: evaluation of short-term efficacy and safety in infants. Exp. Ther. Med. 6, 388\u2013390 (2013).","journal-title":"Exp. Ther. Med."},{"key":"917_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.survophthal.2015.08.006","volume":"61","author":"SL Painter","year":"2016","unstructured":"Painter, S. L. & Hildebrand, G. D. Review of topical beta blockers as treatment for infantile hemangiomas. Surv. Ophthalmol. 61, 51\u201358 (2016).","journal-title":"Surv. Ophthalmol."},{"key":"917_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/0974-2077.138324","volume":"7","author":"G Sethuraman","year":"2014","unstructured":"Sethuraman, G., Yenamandra, V. K. & Gupta, V. Management of infantile hemangiomas: current trends. J. Cutan. Aesthet. Surg. 7, 75\u201385 (2014).","journal-title":"J. Cutan. Aesthet. Surg."},{"key":"917_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet, B. A. et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131, 128\u2013140 (2013).","journal-title":"Pediatrics"},{"key":"917_CR5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.12788\/j.sder.2016.050","volume":"35","author":"CE Cheng","year":"2016","unstructured":"Cheng, C. E. & Friedlander, S. F. Infantile hemangiomas, complications and treatments. Semin. Cutan. Med. Surg. 35, 108\u2013116 (2016).","journal-title":"Semin. Cutan. Med. Surg."},{"key":"917_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jpeds.2007.04.055","volume":"151","author":"S Chamlin","year":"2007","unstructured":"Chamlin, S. et al. Multicenter prospective study of ulcerated hemangiomas. J. Pediatr. 151, 684\u2013689 (2007).","journal-title":"J. Pediatr."},{"key":"917_CR7","first-page":"341","volume":"16","author":"KK Chik","year":"2010","unstructured":"Chik, K. K., Luk, C. K., Chan, H. B. & Tan, H. Y. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med. J. 16, 341\u2013346 (2010).","journal-title":"Hong Kong Med. J."},{"key":"917_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/IOP.0b013e31823bfffb","volume":"28","author":"CB Chambers","year":"2012","unstructured":"Chambers, C. B., Katowitz, W. R., Katowitz, J. A. & Binenbaum, G. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas. Ophthal. Plast. Reconstr. Surg. 28, 103\u2013106 (2012).","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"key":"917_CR9","doi-asserted-by":"publisher","first-page":"e1739","DOI":"10.1542\/peds.2012-3828","volume":"131","author":"H Chan","year":"2013","unstructured":"Chan, H., McKay, C., Adams, S. & Wargon, O. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics 131, e1739\u2013e1747 (2013).","journal-title":"Pediatrics"},{"key":"917_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/archophthalmol.2009.370","volume":"128","author":"S Guo","year":"2010","unstructured":"Guo, S. & Ni, N. Topical treatment for capillary hemangioma of the eyelid using \u03b2-blocker solution. Arch. Ophthalmol. 128, 255\u2013256 (2010).","journal-title":"Arch. Ophthalmol."},{"key":"917_CR11","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2340\/00015555-2681","volume":"97","author":"M Khan","year":"2017","unstructured":"Khan, M. et al. The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis. Acta Derm. Venereol. 97, 1167\u20131171 (2017).","journal-title":"Acta Derm. Venereol."},{"key":"917_CR12","unstructured":"National Institute for Health and Care Excellence. Infantile Haemangioma: Topical Timolol https:\/\/www.nice.org.uk\/advice\/esuom47\/ (2015)."},{"key":"917_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/SAP.0000000000000390","volume":"74","author":"SA Ovadia","year":"2015","unstructured":"Ovadia, S. A., Landy, D. C., Cohen, E. R., Yang, E. Y. & Thaller, S. R. Local administration of \u03b2-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ann. Plast. Surg. 74, 256\u2013262 (2015).","journal-title":"Ann. Plast. Surg."},{"key":"917_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2230.2012.04425.x","volume":"38","author":"K Semkova","year":"2013","unstructured":"Semkova, K. & Kazandjieva, J. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study. Clin. Exp. Dermatol. 38, 143\u2013146 (2013).","journal-title":"Clin. Exp. Dermatol."},{"key":"917_CR15","doi-asserted-by":"publisher","first-page":"e20160355","DOI":"10.1542\/peds.2016-0355","volume":"138","author":"K Puttgen","year":"2016","unstructured":"Puttgen, K. et al. Topical timolol maleate treatment of infantile hemangiomas. Pediatrics 138, e20160355 (2016).","journal-title":"Pediatrics"},{"key":"917_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fonc.2017.00137","volume":"7","author":"HW Wu","year":"2017","unstructured":"Wu, H. W. et al. Topical application of 0.5% timolol maleate hydrogel for the treatment of superficial infantile hemangioma. Front. Oncol. 7, 137 (2017).","journal-title":"Front. Oncol."},{"key":"917_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep19765","volume":"6","author":"J Ge","year":"2016","unstructured":"Ge, J., Zheng, J., Zhang, L., Yuan, W. & Zhao, H. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study. Sci. Rep. 6, 19765 (2016).","journal-title":"Sci. Rep."},{"key":"917_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1525-1470.2011.01664.x","volume":"29","author":"A Chakkittakandiyil","year":"2012","unstructured":"Chakkittakandiyil, A. et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr. Dermatol. 29, 28\u201331 (2012).","journal-title":"Pediatr. Dermatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0917-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0917-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:13Z","timestamp":1684618273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0917-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["917"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-0917-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Hospital Authority Kowloon East Cluster Clinical Research Ethics Committee (Reference number: KC\/KE-16-0187\/FR-2; Prospective approval in 2016). Australian New Zealand Clinical Trials Registry (Registration number: ACTRN12619001685101; Retrospective approval in 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and clinical trial registration"}}]}}